Results 1 to 10 of about 1,227,180 (211)

Diagnostic value of pentraxin 3 in plasma and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in non-neutropenic patients: a prospective multicenter clinical study. [PDF]

Emerg Microbes Infect
Sun C, Zhong H, Cai X, Cao M, Zhao T, Wang L, Feng C, Sun W, Chen C, Chen Y, Tao Y, Zhou J, Ni Y, Gu Y, Shi M, Lu X, Ma G, Li Y, Shi J, Cai Y, Song M, Li Y, Lu Y, Zhong J, Shi Y, Su X.   +25 more
europepmc   +1 more source

Antagonistic interaction between posaconazole and olorofim in a murine model of invasive pulmonary aspergillosis. [PDF]

J Antimicrob Chemother
Darlow CA, Farrington N, Märtson AG, Johnson A, McEntee L, Horner I, Stevenson A, Jimenez-Valverde A, Unsworth J, Das S, Hope W.   +10 more
europepmc   +1 more source

Fatal AA-like bone marrow failure and invasive pulmonary aspergillosis after long-term pembrolizumab in squamous NSCLC: a case report. [PDF]

Front Immunol
Wang Y, Dong W, Qin J.
europepmc   +1 more source

A meta-analysis-informed diagnostic stratification tool for invasive pulmonary aspergillosis in severe fever with thrombocytopenia syndrome: systematic review, meta-analysis, and single-center cohort-based assessment. [PDF]

Front Cell Infect Microbiol
Ma R, Ding S, Xu Y, Wang J, Zhang R, Ge Z, Tian D, Wu H, Mu Y, Ren B, Lin L, Chen Z.   +11 more
europepmc   +1 more source

Emerging Risk Factors for Invasive Pulmonary Aspergillosis: A Narrative Review. [PDF]

J Fungi (Basel)
Elkhapery A, Fatima M, Soubani AO.
europepmc   +1 more source

Synergistic effects of S100 calcium-binding protein A12 combined with Pentraxin 3 in invasive pulmonary aspergillosis and their clinical application prospects. [PDF]

Front Cell Infect Microbiol
Zhou XL, Hu XB, Liu H.
europepmc   +1 more source

Invasive Pulmonary Aspergillosis

Respiration, 2002
<i>Background:</i> Invasive pulmonary aspergillosis usually occurs in immunocompromised patients. Mild abnormality of host defence is usually present in the chronic necrotising form of the disease. Acute aspergillus pneumonia usually affects patients who are seriously immunocompromised.
Sabina Skrgat, Kristan, Izidor, Kern, Ema, Music   +2 more
  +7 more sources

Invasive pulmonary aspergillosis/pseudomonas

BMJ Case Reports, 2021
A 47-year-old Caucasian man on long-standing antifungal therapy for chronic necrotising aspergillosis and a history of recurrent pseudomonas pneumonias presented to the outpatient pulmonary clinic with dyspnoea and chest discomfort for 3 days. A CT angiography of the chest demonstrated angioinvasion from the previously noted left upper lobe cavitary ...
Menaka Mahendran, Daniel Urbine
openaire   +2 more sources

Invasive Pulmonary Aspergillosis

Seminars in Respiratory and Critical Care Medicine, 2004
Invasive pulmonary aspergillosis (IPA) is the most common fungal pulmonary infection in severely immunocompromised patients. Aspergillus species are commonly isolated from the soil, plant debris, and the indoor environment, including the hospital. Phagocytosis is the main host defense against Aspergillus conidia and hyphae.
Raoul, Herbrecht, Shanti, Natarajan-Amé, Valérie, Letscher-Bru, Matthieu, Canuet   +3 more
openaire   +2 more sources

Invasive Pulmonary Aspergillosis

JAMA: The Journal of the American Medical Association, 1980
To the Editor:— In reference to the article "Invasive Pulmonary Aspergillosis Associated With Influenza" by Fischer and Walker (241:1493, 1979), mention is made that invasive pulmonary aspergillosis is usually seen in the compromised host and that invasive disease is rare in normal persons. The authors mention only 13 cases of pulmonary aspergillosis
openaire   +2 more sources